<!DOCTYPE html>
<html class="">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>Pulmonary embolism - Prevention | BMJ Best Practice</title>
      <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
      <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
      <meta name="description" content="Pulmonary embolism (PE) is a life-threatening condition resulting from dislodged thrombi occluding the pulmonary vasculature; right heart failure and cardiac arrest may ensue if not aggressively treated. Symptoms include chest pain, dyspnoea, and a sense of apprehension. Haemoptysis and syncope a...">
      <!-- Optimize Page Hiding Snippet --> 
      <!-- <style>.async-hide
         { opacity: 0 !important}
      </style>
      <script async="" src="../js/adrum-ext.0086dbec5e8a6e717bf36d3a06b62042.js"></script><script src="../js/414393182248444" async=""></script><script async="" src="../js/fbevents.js"></script><script type="text/javascript" async="" src="../js/analytics.js"></script><script async="" src="../js/get-loader.js"></script><script type="text/javascript" async="" src="../js/insight.min.js"></script><script type="text/javascript" async="" src="../js/js"></script><script type="text/javascript" async="" src="../js/uwt.js"></script><script type="text/javascript" async="" src="../js/4896.js"></script><script type="text/javascript" async="" src="../js/analytics.js"></script><script async="" src="../js/gtm.js"></script><script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date; h.end=i=function()
         {s.className=s.className.replace(RegExp(' ?'+y),'')}
         ; (a[n]=a[n]||[]).hide=h;setTimeout(function()
         
         {i();h.end=null}
         ,c);h.timeout=c;})(window,document.documentElement,'async-hide','dataLayer',3000,
         
         {'GTM-K3TZ3JV':true}
         );
      </script> -->
      <!-- end Optimize Page Hiding Snippet -->
      <!-- Google Tag Manager -->
      <script>
         /*<![CDATA[*/
         
          
         window.dataLayer = window.dataLayer || [];
         window.dataLayer.push({
                    'icsId': null,
                    'pi_icsId': "id82087",
                    'pi_icsName': "BMJ Group (Online access from BMA House)",
                    'access_rights': true,
                    'ics_groupings': [{"name":"Country Grouping"}],
                    'ics_countryName': "GB and ROW",
                    'siteLanguage': "en-gb",
                    'contentLanguage': "en-gb"
                 });
         		  
         /*]]>*/
            
      </script>
      <script>
         (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
         new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
         j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
         'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
         })(window,document,'script','dataLayer', 'GTM-K3TZ3JV');
      </script>
      <!-- End Google Tag Manager -->
      <!-- /* if user in China */ -->
      <link rel="stylesheet" type="text/css" media="screen" href="../css/material.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/styles.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/external.css">
      <link rel="shortcut icon" href="https://resources.bmj.com/repository/images/favicon.ico">
      <link rel="canonical" href="https://bestpractice.bmj.com/topics/en-gb/116/prevention">
      <link rel="alternate" hreflang="uk-ua" href="https://bestpractice.bmj.com/topics/uk-ua/116/prevention">
      <link rel="alternate" hreflang="en-ie" href="https://bestpractice.bmj.com/topics/en-gb/116/prevention">
      <link rel="alternate" hreflang="az-az" href="https://bestpractice.bmj.com/topics/az-az/116/prevention">
      <link rel="alternate" hreflang="en-us" href="https://bestpractice.bmj.com/topics/en-us/116/prevention">
      <link rel="alternate" hreflang="ru" href="https://bestpractice.bmj.com/topics/ru-ru/116/prevention">
      <link rel="alternate" hreflang="pt" href="https://bestpractice.bmj.com/topics/pt-br/116/prevention">
      <link rel="alternate" hreflang="ka-ge" href="https://bestpractice.bmj.com/topics/ka-ge/116/prevention">
      <link rel="alternate" hreflang="pt-br" href="https://bestpractice.bmj.com/topics/pt-br/116/prevention">
      <link rel="alternate" hreflang="en" href="https://bestpractice.bmj.com/topics/en-gb/116/prevention">
      <link rel="alternate" hreflang="es-es" href="https://bestpractice.bmj.com/topics/es-es/116/prevention">
      <link rel="alternate" hreflang="zh-cn" href="https://bestpractice.bmj.com/topics/zh-cn/116/prevention">
      <link rel="alternate" hreflang="es" href="https://bestpractice.bmj.com/topics/es-es/116/prevention">
      <link rel="alternate" hreflang="zh" href="https://bestpractice.bmj.com/topics/zh-cn/116/prevention">
      <link rel="alternate" hreflang="x-default" href="https://bestpractice.bmj.com/topics/en-gb/116/prevention">
      <link rel="alternate" hreflang="ru-ru" href="https://bestpractice.bmj.com/topics/ru-ru/116/prevention">
      <link rel="alternate" hreflang="vi" href="https://bestpractice.bmj.com/topics/vi-vn/116/prevention">
      <link rel="alternate" hreflang="uk" href="https://bestpractice.bmj.com/topics/uk-ua/116/prevention">
      <link rel="alternate" hreflang="ka" href="https://bestpractice.bmj.com/topics/ka-ge/116/prevention">
      <link rel="alternate" hreflang="az" href="https://bestpractice.bmj.com/topics/az-az/116/prevention">
      <link rel="alternate" hreflang="vi-vn" href="https://bestpractice.bmj.com/topics/vi-vn/116/prevention">
      <link rel="alternate" hreflang="en-gb" href="https://bestpractice.bmj.com/topics/en-gb/116/prevention">
      <!--[if lte IE 9]>
      <link rel="stylesheet" type="text/css" media="screen" href="/gzip_1791a8687c5480ce19e791d0825e7a6b/css/lte-ie-9.css" >
      <![endif]-->
      <script>
         /*<![CDATA[*/
           var appdynamics_app_key="AD-AAB-AAF-RGR";
         /*]]>*/
           	window["adrum-app-key"] = appdynamics_app_key;
           	window['adrum-start-time'] = new Date().getTime();
           
      </script>
      <script type="text/javascript" src="../js/appdynamics.js"></script>
      <script type="application/ld+json">
         [
         
         { "@context": "http://schema.org", "@type": "MedicalCondition" }
         ,{
         "isAccessibleForFree": "False",
         "hasPart":
         
         { "@type": "WebPageElement", "isAccessibleForFree": "False", "cssSelector" : ".gpw" }
         }]
      </script>
      <style></style>
   </head>
   <body class="gpw">
      <div role="dialog" aria-live="polite" aria-label="cookieconsent" aria-describedby="cookieconsent:desc" class="cc-window cc-banner cc-type-info cc-theme-classic cc-bottom cc-color-override--38786966 cc-invisible" style="display: none;">
         <!--googleoff: all--><span id="cookieconsent:desc" class="cc-message">We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our 
         <a aria-label="learn more about cookies" role="button" tabindex="0" class="cc-link" href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">cookies policy</a></span>
         <div class="cc-compliance"><a aria-label="dismiss cookie message" role="button" tabindex="0" class="cc-btn cc-dismiss">OK!</a></div>
         <!--googleon: all-->
      </div>
      <!-- Google Tag Manager (noscript) -->
      <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K3TZ3JV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
      <!-- End Google Tag Manager (noscript) -->
      <!-- /* if user in China */ -->
      <header id="header" role="banner">
         <a class="sr-only" href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#sr-content">Skip to main content</a>
         <div class="bg-info text-white">
         </div>
         <nav id="globalNav" class="logo-img-mob navbar navbar-toggleable-md">
            <div class="container">
               <a href="https://bestpractice.bmj.com/" class="mobLogo"><span class="remove"><abbr>BMJ</abbr> Best Practice</span></a>
               <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
               <span class="material-icons"></span>
               </button>
               <div id="navbarNav" class="collapse navbar-collapse">
                  <ul id="globalNav-ul" class="navbar-nav" role="menubar">
                     <li id="globalNav-access" class="nav-item" role="presentation">
                        <span class="nav-link"> 
                        Access provided by: 
                        BMJ Group (Online access from BMA House)
                        </span>
                     </li>
                     <li id="globalNav-help" class="nav-item dropdown" role="menuitem">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#" id="navbarDropdownMenuLink02" class="nav-link dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> 
                        Help <span class="states">
                        <span class="material-icons"></span>
                        <span class="material-icons"></span>
                        </span>
                        </a>
                        <div id="globalNav-help-options" class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownMenuLink02">
                           <span class="material-icons"></span>
                           <ul role="menu">
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></li>
                           </ul>
                        </div>
                     </li>
                     <li id="globalNav-register" class="nav-item">
                        <a href="https://bestpractice.bmj.com/registration" class="nav-link">Create account</a>
                     </li>
                     <li id="globalNav-login" class="nav-item">
                        <a href="https://bestpractice.bmj.com/login" class="nav-link">Log in</a>
                     </li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
         <div id="mainSearch" class="container">
            <div class="row">
               <div class="col-lg-7">
                  <div class="logo-img"><a href="https://bestpractice.bmj.com/"><span class="remove"><abbr title="British Medical Journal">BMJ</abbr> Best Practice</span></a></div>
               </div>
               <div class="col-lg-5">
                  <style type="text/css">
                     #searchBoxWrap .tt-open:before {content: "Recently viewed topics:"; }
                     #searchBoxWrap .tt-label-override:before,
                     #searchBoxWrap .tt-suggested:before {content: "Suggested topics:" !important; }
                  </style>
                  <form id="searchBoxForm" action="https://bestpractice.bmj.com/search" role="search" novalidate="novalidate">
                     <div class="input-group">
                        <div id="searchBoxWrap">
                           <label for="q" class="sr-only">Search</label>
                           <span class="twitter-typeahead" style="position: relative; display: inline-block;">
                              <input id="q" type="text" name="q" placeholder="Search conditions, symptoms..." value="" class="tt-input" autocomplete="off" spellcheck="false" dir="auto" style="position: relative; vertical-align: top;">
                              <pre aria-hidden="true" style="position: absolute; visibility: hidden; white-space: pre; font-family: sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; word-spacing: 0px; letter-spacing: 0px; text-indent: 0px; text-rendering: auto; text-transform: none;"></pre>
                              <div class="tt-menu" style="position: absolute; top: 100%; left: 0px; z-index: 100; display: none;">
                                 <div class="tt-dataset tt-dataset-0"></div>
                              </div>
                           </span>
                           <button id="mainSearchBtn" type="submit"><span class="material-icons"></span></button>
                        </div>
                     </div>
                  </form>
                  <script>
                     /*<![CDATA[*/
                     
                            // These are required in completion, see BP-232 -->
                            var searchDefaultLanguageCode = "en-gb";
                            var regionName = "GB and ROW";
                            var regionAvailableLanguagesCodes = [{"id":"1","code":"en-gb","displayName":"English"},{"id":"3","code":"pt-br","displayName":"Portugu\u00EAs"},{"id":"5","code":"es-es","displayName":"Espa\u00F1ol"},{"id":"7","code":"ru-ru","displayName":"\u0420\u0443\u0441\u0441\u043A\u0438\u0439"}];
                            var availableLanguages = [];
                     
                            for (i = 0; i < regionAvailableLanguagesCodes.length; i++) {
                                availableLanguages.push(regionAvailableLanguagesCodes[i].code);
                            }
                     /*]]>*/
                  </script>
               </div>
            </div>
         </div>
         <nav id="mainNav" class="navbar navbar-toggleable-md" role="navigation">
            <div class="container">
               <div id="mainNavbarNav">
                  <ul class="navbar-nav" role="menubar">
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
      </header>
      <main id="tmp" class="container tmp tmp-basic main-container" role="main">
         <script type="text/javascript">
            /*<![CDATA[*/ 
            var topicId = 116; 
            var langCode="en-gb"; 
            /*]]>*/
         </script>
         <div id="topicNav" class="container">
            <div class="lang">
               <ul role="menu">
                  <li><a href="https://bestpractice.bmj.com/topics/en-gb/116" class="active">English</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/pt-br/116">Português</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/es-es/116">Español</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/ru-ru/116">Русский</a></li>
               </ul>
            </div>
            <div id="topicMenuTopBg" style="height: 110px;"></div>
            <div id="topicMenuTopWrap" style="height: 110px;">
               <div id="topicMenuTop" style="height: 110px;">
                  <h1>Pulmonary embolism</h1>
                  <div class="pdf-links-nav">
                     <div class="pdf">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/pdf/116.pdf" target="_blank">
                        <span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span>
                        </a>
                     </div>
                  </div>
                  <div id="mobileMenu" class="mUp">
                     <a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#" role="button">
                     <span><span class="material-icons"></span> Menu</span>
                     <span><span class="material-icons"></span> Close</span>
                     </a>
                  </div>
                  <ul id="menuLinks" role="menu">
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#smenu-0" aria-owns="menu-0">Overview <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#smenu-1" aria-owns="menu-1">Theory <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#smenu-2" aria-owns="menu-2">Diagnosis <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#smenu-3" aria-owns="menu-3">Management <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#smenu-4" aria-owns="menu-4">Follow up <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#smenu-5" aria-owns="menu-5">Resources <span class="material-icons"></span><span class="material-icons"></span></a></li>
                  </ul>
               </div>
            </div>
            <div id="topicMenuBottomWrap" style="height: 176px;">
               <nav id="topicMenuBottom" class="mUp" role="navigation" style="height: 176px;">
                  <ul id="menus" role="menubar">
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Overview</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-0">
                           <li><a href="116_overview_summary.html" id="Summary">Summary</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Theory</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-1">
                           <li><a href="116_theory_epidemiology.html" id="Epidemiology">Epidemiology</a></li>
                           <li><a href="116_theory_aetiology.html" id="Aetiology">Aetiology</a></li>
                           <li><a href="116_theory_case_history.html" id="Case history">Case history</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Diagnosis</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-2">
                           <li><a href="116_diagnosis_recommendations.html" id="Approach">Recommendations</a></li>
                           <li><a href="116_diagnosis_history-exam.html" id="History and exam">History and exam</a></li>
                           <li><a href="116_diagnosis_investigations.html" id="Investigations">Investigations</a></li>
                           <li><a href="116_diagnosis_differentials.html" id="Differentials">Differentials</a></li>
                           <li><a href="116_diagnosis_criteria.html" id="Criteria">Criteria</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Management</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-3">
                           <li><a href="116_management_recommendations.html" id="Approach">Recommendations</a></li>
                           <li><a href="116_management_treatment_algorithm.html" id="Treatment algorithm">Treatment algorithm</a></li>
                           <li><a href="116_management_emerging.html" id="Emerging">Emerging</a></li>
                           <li><a href="116_management_prevention.html" id="Prevention" class="active">Prevention</a></li>
                           <li><a href="116_management_patient_discussions.html" id="Patient discussions">Patient discussions</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Follow up</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-4">
                           <li><a href="116_follow_up_monitoring.html" id="Monitoring">Monitoring</a></li>
                           <li><a href="116_follow_up_complications.html" id="Complications">Complications</a></li>
                           <li><a href="116_follow_up_prognosis.html" id="Prognosis">Prognosis</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/criteria#" class="parent"><span>Resources</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-5">
                           <li><a href="116_resources_guidelines.html" id="Guidelines">Guidelines</a></li>
                           <li><a href="116_resources_images_videos.html" id="Images and videos">Images and videos</a></li>
                           <li><a href="116_resources_references.html" id="References">References</a></li>
                           <li><a href="116_resources_patient_leaflets.html" id="Patient leaflets">Patient leaflets</a></li>
                           <li><a href="116_resources_evidence.html" id="Evidence">Evidence</a></li>
                        </ul>
                     </li>
                     <li class="mpdf"><a href="https://bestpractice.bmj.com/topics/en-gb/116/pdf/116.pdf" target="_blank"><span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span></a></li>
                  </ul>
               </nav>
            </div>
         </div>
         <h2 id="sr-content">Primary prevention</h2>
         <div class="card">
            <div class="card-block">
               <!-- Primary prevention section-->
               <p class="w-75">
                  <!-- col-md-9 -->
                  Specific recommendations exist for the primary prevention of venous thromboembolism (VTE) in several patient populations.
                  <span class="reference"> 
                  <a href="#referencePop64" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[64]</a> 
                  <span class="citationText" aria-hidden="true">Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e691S-736S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60136-6/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315276?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop65" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[65]</a> 
                  <span class="citationText" aria-hidden="true">Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315261?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop66" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[66]</a> 
                  <span class="citationText" aria-hidden="true">Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60126-3/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315265?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Approaches include pharmacological prophylaxis (e.g, low molecular weight heparins [LMWH], unfractionated heparin, direct-acting oral anticoagulants, fondaparinux) and mechanical thromboprophylaxis (e.g., graduated compression stockings, intermittent pneumatic compression [IPC]).
                  <span class="reference"> 
                  <a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                  [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                  </a>
                  <span class="ccaTitle" aria-hidden="true">How does low‐molecular‐weight heparin (LMWH) compare with unfractionated heparin (UFH) for adults with an acute medical illness and reduced mobility?</span>
                  <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.2288/full</span>
                  <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Inferior vena cava (IVC) filters are not recommended for the primary prevention of VTE in general surgery, abdominal-pelvic surgery, or major trauma patients.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;The efficacy of IVC filters for the prevention of PE remains unclear.
                  <span class="reference"> 
                  <a href="#referencePop68" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[68]</a> 
                  <span class="citationText" aria-hidden="true">Kidane B, Madani AM, Vogt K, et al. The use of prophylactic inferior vena cava filters in trauma patients: a systematic review. Injury. 2012 May;43(5):542-7.</span> 
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22386925?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop69" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[69]</a> 
                  <span class="citationText" aria-hidden="true">Bikdeli B, Chatterjee S, Desai NR, et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis. J Am Coll Cardiol. 2017 Sep 26;70(13):1587-97.</span> 
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/28935036?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop70" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[70]</a> 
                  <span class="citationText" aria-hidden="true">Mont MA, Jacobs JJ, Boggio LN, et al; AAOS. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg. 2011 Dec;19(12):768-76.</span> 
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22134209?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Non-surgical patients
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Anticoagulant thromboprophylaxis with LMWH, low-dose unfractionated heparin, or fondaparinux is recommended for acutely ill hospitalised medical patients at increased risk of VTE.
                  <span class="reference"> 
                  <a href="#referencePop65" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[65]</a> 
                  <span class="citationText" aria-hidden="true">Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315261?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                  [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                  </a>
                  <span class="ccaTitle" aria-hidden="true">How does low‐molecular‐weight heparin (LMWH) compare with unfractionated heparin (UFH) for adults with an acute medical illness and reduced mobility?</span>
                  <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.2288/full</span>
                  <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                  </span>
                  &nbsp;In the presence of bleeding, or if the patient is at high risk for major bleeding, mechanical thromboprophylaxis with graduated compression stockings or IPC is recommended. IPC may be preferred in hospitalised medical patients with stroke.
                  <span class="reference"> 
                  <a href="#referencePop71" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[71]</a> 
                  <span class="citationText" aria-hidden="true">Dennis M, Sandercock P, Graham C, et al; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness. Health Technol Assess. 2015 Sep;19(76):1-90.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://www.journalslibrary.nihr.ac.uk/hta/hta19760/#/abstract
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26418530?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Neither pharmacological nor mechanical prophylaxis is recommended for acutely ill non-surgical hospitalised patients at low risk of thrombosis.
                  <span class="reference"> 
                  <a href="#referencePop65" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[65]</a> 
                  <span class="citationText" aria-hidden="true">Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315261?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Orthopaedic surgery patients
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Prophylaxis (for a period of 10 to 14 days) with LMWH, fondaparinux, apixaban, dabigatran, rivaroxaban, low-dose unfractionated heparin, adjusted-dose vitamin K antagonist, aspirin, or IPC is recommended in patients undergoing elective hip or knee replacement surgery.
                  <span class="reference"> 
                  <a href="#referencePop66" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[66]</a> 
                  <span class="citationText" aria-hidden="true">Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60126-3/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315265?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Thromboprophylaxis for up to 35 days from the day of surgery is recommended following major orthopaedic surgery.
                  <span class="reference"> 
                  <a href="#referencePop66" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[66]</a> 
                  <span class="citationText" aria-hidden="true">Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60126-3/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315265?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  LMWH, fondaparinux, low-dose unfractionated heparin, adjusted-dose vitamin K antagonist, aspirin, or IPC (for a period of 10 to 14 days) is recommended for patients undergoing hip fracture surgery.
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Early mobilisation lowers risk of VTE following total hip replacement.
                  <span class="reference"> 
                  <a href="#referencePop72" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[72]</a> 
                  <span class="citationText" aria-hidden="true">White RH, Gettner S, Newman JM, et al. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000 Dec 14;343(24):1758-64.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://www.nejm.org/doi/10.1056/NEJM200012143432403
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/11114314?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  General and abdominal-pelvic surgery
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Early mobilisation is recommended for patients at very low risk for VTE.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Mechanical prophylaxis with IPC is recommended for low-risk general and abdominal-pelvic surgery patients.
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  For general and abdominal-pelvic surgery patients who are at moderate risk for VTE but not at high risk for major bleeding complications, LMWH, low-dose unfractionated heparin, or IPC are recommended.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Patients at moderate risk for VTE who are at high risk for major bleeding complications, or for whom the consequences of major bleeding would be severe, should receive mechanical prophylaxis with IPC.
                  <span class="reference"> 
                  <a href="#referencePop73" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[73]</a> 
                  <span class="citationText" aria-hidden="true">Kakkos SK, Caprini JA, Geroulakos G, et al. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database Syst Rev. 2016 Sep 7;(9):CD005258.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD005258.pub3/full
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/27600864?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  High-risk patients who are not at high risk for major bleeding complications should receive LMWH or low-dose unfractionated heparin, and mechanical prophylaxis (elastic stockings or IPC).
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Low-dose aspirin, fondaparinux, or mechanical prophylaxis are alternatives if LMWH and unfractionated heparin are contraindicated. IPC is recommended for patients at high risk for major bleeding complications, or those for whom the consequences of bleeding are thought to be severe. 
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Pregnancy
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  LMWH is recommended for the prevention of VTE in pregnant women at increased risk of VTE.
                  <span class="reference"> 
                  <a href="#referencePop64" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[64]</a> 
                  <span class="citationText" aria-hidden="true">Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e691S-736S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60136-6/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315276?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;For women who fulfil the laboratory and clinical (a history of 3 or more pregnancy losses) criteria for antiphospholipid syndrome, antepartum administration of prophylactic or intermediate-dose unfractionated heparin, or prophylactic LMWH combined with low-dose aspirin, is recommended. Antithrombotic prophylaxis is not recommended for: women with inherited thrombophilia and a history of pregnancy complications; or women with 2 or more miscarriages, but without antiphospholipid antibodies or thrombophilia.
                  <span class="reference"> 
                  <a href="#referencePop64" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[64]</a> 
                  <span class="citationText" aria-hidden="true">Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e691S-736S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60136-6/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315276?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Cancer and surgical patients with cancer
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Prophylactic-dose LMWH or low-dose unfractionated heparin is recommended for outpatients with solid tumours who have additional risk factors for VTE and who are at low risk of bleeding.
                  <span class="reference"> 
                  <a href="#referencePop65" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[65]</a> 
                  <span class="citationText" aria-hidden="true">Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315261?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Routine pharmacological prophylaxis is not recommended for outpatients with cancer who have no additional risk factors for VTE.
                  <span class="reference"> 
                  <a href="#referencePop65" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[65]</a> 
                  <span class="citationText" aria-hidden="true">Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315261?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Patients at high risk of VTE who are undergoing abdominal or pelvic surgery for cancer, and who are not otherwise at high risk for major bleeding complications, should receive extended pharmacological prophylaxis (4 weeks) with LMWH.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Pharmacological thromboprophylaxis is not recommended in outpatients with cancer for the prevention of catheter-related thrombosis.
                  <span class="reference"> 
                  <a href="#referencePop65" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[65]</a> 
                  <span class="citationText" aria-hidden="true">Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315261?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Cardiac and thoracic surgery
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Cardiac surgery patients with an uncomplicated postoperative course should receive mechanical prophylaxis, preferably with IPC.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;For those cardiac surgery patients whose hospital stay is prolonged by a non-haemorrhagic surgical complication, LMWH or low-dose unfractionated heparin can be added to mechanical prophylaxis.
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  LMWH, low-dose unfractionated heparin, or IPC is recommended for thoracic surgery patients at moderate risk for VTE who are not at high risk for perioperative bleeding.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;For thoracic surgery patients at high risk for VTE who are not at high risk for perioperative bleeding, LMWH or low-dose unfractionated heparin, plus IPC or elastic stockings, is recommended. IPC is recommended for thoracic surgery patients at high risk for major bleeding.
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Major trauma patients
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  LMWH, low-dose unfractionated heparin, or IPC is recommended for the prevention of VTE in major trauma patients.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Pharmacological prophylaxis is recommended for patients at high risk for VTE (e.g., those with acute spinal cord injury, traumatic brain injury, and spinal surgery for trauma); mechanical prophylaxis can be added when not contraindicated by lower extremity injury.
                  <span class="reference"> 
                  <a href="#referencePop73" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[73]</a> 
                  <span class="citationText" aria-hidden="true">Kakkos SK, Caprini JA, Geroulakos G, et al. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database Syst Rev. 2016 Sep 7;(9):CD005258.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD005258.pub3/full
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/27600864?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;IPC is recommended (if not contraindicated) for major trauma patients in whom LMWH and low-dose unfractionated heparin are contraindicated.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Craniotomy and spinal surgery
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  IPC is recommended for the prevention of VTE in craniotomy and spinal surgery patients.
                  <span class="reference"> 
                  <a href="#referencePop67" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[67]</a> 
                  <span class="citationText" aria-hidden="true">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e227S-77S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60125-1/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315263?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;For craniotomy and spinal surgery patients at very high risk for VTE (e.g., those with malignant disease), pharmacological prophylaxis can be added to mechanical prophylaxis when homeostasis is established and bleeding risk declines.
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Long-distance travel
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Neither aspirin nor anticoagulants is recommended for prevention of VTE in long-distance travellers.
                  <span class="reference"> 
                  <a href="#referencePop65" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[65]</a> 
                  <span class="citationText" aria-hidden="true">Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(12)60124-X/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/22315261?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Those travellers at increased risk of VTE (e.g., recent surgery or trauma, active malignancy, pregnancy) should: use properly fitted, below-knee graduated compression stockings providing 15 to 30 mmHg of pressure at the ankle during travel; move or walk about frequently; exercise calf muscles; and sit in an aisle seat (if possible).
               </p>
            </div>
         </div>
         <h2>Secondary prevention</h2>
         <div class="card">
            <div class="card-block">
               <!-- Secondary prevention section-->
               <p class="w-75">
                  <!-- col-md-9 -->
                  Guidelines recommend the following oral anticoagulant treatment durations:
                  <span class="reference"> 
                  <a href="#referencePop76" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[76]</a> 
                  <span class="citationText" aria-hidden="true">Konstantinides SV, Torbicki A, Agnelli G, et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14;35(43):3033-69.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://academic.oup.com/eurheartj/article/35/43/3033/503581
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/25173341?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <ul class="w-75">
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        PE provoked by surgery: 3 months
                     </p>
                  </li>
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        PE provoked by a non-surgical transient risk factor: 3 months
                     </p>
                  </li>
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        Unprovoked PE with low or moderate bleeding risk: extended anticoagulant therapy (i.e., no scheduled stop date) with periodic reassessment to review risk-benefit ratio
                     </p>
                  </li>
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        Unprovoked PE with high bleeding risk: 3 months.
                     </p>
                  </li>
               </ul>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Evidence from studies of ≥6 months’ duration suggests that there are no differences between direct-acting oral anticoagulants and conventional anticoagulation for the management of PE,
                  <span class="reference"> 
                  <a href="#referencePop238" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[238]</a> 
                  <span class="citationText" aria-hidden="true">Robertson L, Kesteven P, McCaslin JE. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. Cochrane Database Syst Rev. 2015 Dec 4;(12):CD010957.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD010957.pub2/full
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26636644?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop239" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[239]</a> 
                  <span class="citationText" aria-hidden="true">Becattini C, Agnelli G. Risk stratification and management of acute pulmonary embolism. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):404-12.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  http://asheducationbook.hematologylibrary.org/content/2016/1/404.long
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/27913508?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;and there is usually no need to change the initial oral anticoagulant in patients who receive continued (&gt;3 months) anticoagulation therapy.
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;However, reduced-intensity or low-intensity anticoagulation with rivaroxaban or apixaban significantly reduced the risk of recurrent events in patients with venous thromboembolism (VTE) who had previously completed 6 to 12 months of standard anticoagulation therapy (e.g., with a vitamin K antagonist, enoxaparin, or a direct-acting oral anticoagulant agent such as dabigatran, rivaroxaban, apixaban, or edoxaban).
                  <span class="reference"> 
                  <a href="#referencePop240" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[240]</a> 
                  <span class="citationText" aria-hidden="true">Weitz JI, Lensing AW, Prins MH, et al; EINSTEIN CHOICE Investigators. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med. 2017 Mar 30;376(13):1211-22.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://www.nejm.org/doi/10.1056/NEJMoa1700518
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/28316279?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop241" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[241]</a> 
                  <span class="citationText" aria-hidden="true">Agnelli G, Buller HR, Cohen A, et al; AMPLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013 Feb 21;368(8):699-708.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://www.nejm.org/doi/10.1056/NEJMoa1207541
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/23216615?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;Neither rivaroxaban nor apixaban was associated with an increased risk of bleeding.
                  <span class="reference"> 
                  <a href="#referencePop240" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[240]</a> 
                  <span class="citationText" aria-hidden="true">Weitz JI, Lensing AW, Prins MH, et al; EINSTEIN CHOICE Investigators. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med. 2017 Mar 30;376(13):1211-22.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://www.nejm.org/doi/10.1056/NEJMoa1700518
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/28316279?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop241" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[241]</a> 
                  <span class="citationText" aria-hidden="true">Agnelli G, Buller HR, Cohen A, et al; AMPLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013 Feb 21;368(8):699-708.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://www.nejm.org/doi/10.1056/NEJMoa1207541
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/23216615?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Recommendations for continuation of anticoagulant therapy vary by patient population. In all patients who receive extended anticoagulant therapy, its continued use should be re-assessed at periodic intervals (such as annually).
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Active cancer
               </p>
               <ul class="w-75">
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        Low molecular weight heparin (LMWH) is preferred over a vitamin K antagonist (VKA), dabigatran, rivaroxaban, apixaban, or edoxaban for the treatment of PE in patients with active malignancy.
                        <span class="reference"> 
                        <a href="#referencePop76" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[76]</a> 
                        <span class="citationText" aria-hidden="true">Konstantinides SV, Torbicki A, Agnelli G, et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14;35(43):3033-69.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://academic.oup.com/eurheartj/article/35/43/3033/503581
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/25173341?tool=bestpractice.com
                        </span>
                        </span>
                        <span class="reference"> 
                        <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                        <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                        </span>
                        </span>
                        <span class="reference"> 
                        <a href="#referencePop211" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[211]</a> 
                        <span class="citationText" aria-hidden="true">Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014. J Clin Oncol. 2015 Feb 20;33(6):654-6.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        http://ascopubs.org/doi/full/10.1200/JCO.2014.59.7351
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/25605844?tool=bestpractice.com
                        </span>
                        </span>
                        <span class="reference"> 
                        <a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                        [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                        </a>
                        <span class="ccaTitle" aria-hidden="true">How do low‐molecular‐weight heparin (LMWH), vitamin K agonists (VKAs), and direct oral anticoagulants (DOACs) compare for treatment of venous thromboembolism (VTE) in people with cancer?</span>
                        <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.2255/full</span>
                        <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                        </span>
                        &nbsp;European guidelines recommend anticoagulant therapy for a period of 3 to 6 months;
                        <span class="reference"> 
                        <a href="#referencePop76" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[76]</a> 
                        <span class="citationText" aria-hidden="true">Konstantinides SV, Torbicki A, Agnelli G, et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14;35(43):3033-69.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://academic.oup.com/eurheartj/article/35/43/3033/503581
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/25173341?tool=bestpractice.com
                        </span>
                        </span>
                        &nbsp;the American College of Chest Physicians (ACCP) recommends extended anticoagulant therapy (i.e., no scheduled stop date).
                        <span class="reference"> 
                        <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                        <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                        </span>
                        </span>
                        &nbsp;LMWH is more effective than a VKA in patients with cancer (moderate-quality evidence), is therapeutically reliable in patients for whom oral therapy may be inappropriate (e.g., vomiting), and is easier to adjust/withhold if thrombocytopenia develops or an invasive intervention is needed.
                        <span class="reference"> 
                        <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                        <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                        </span>
                        </span>
                        &nbsp;Furthermore, patients with cancer treated with a VKA may be difficult to maintain within the therapeutic range, and experience substantial rates of recurrence.
                        <span class="reference"> 
                        <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                        <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                        </span>
                        </span>
                        &nbsp;
                     </p>
                  </li>
               </ul>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Renal impairment
               </p>
               <ul class="w-75">
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        The American College of Chest Physicians (ACCP) recommends a VKA for patients with severe renal impairment (i.e., creatinine clearance &lt;30 mL/minute).
                        <span class="reference"> 
                        <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                        <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                        </span>
                        </span>
                        &nbsp;Health professionals should refer to the label and/or local formularies before prescribing a direct-acting oral anticoagulant for a patient with renal impairment.
                     </p>
                  </li>
               </ul>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Hepatic impairment and coagulopathy
               </p>
               <ul class="w-75">
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        ACCP guidelines recommend LMWH in this patient population.
                        <span class="reference"> 
                        <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                        <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                        https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                        </span>
                        </span>
                        &nbsp;Health professionals should refer to the label and/or local formularies before prescribing a direct-acting oral anticoagulant for a patient with hepatic impairment.
                     </p>
                  </li>
               </ul>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Patients with recurrent VTE on anticoagulant therapy
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Recurrent VTE is unusual among patients receiving therapeutic-dose anticoagulant therapy.
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;In addition to definitively establishing the presence of recurrent PE, consideration should be given to compliance with anticoagulant therapy or the presence of underlying malignancy.
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  ACCP guidelines recommend a temporary switch to LMWH (for at least 1 month) for patients with recurrent PE who are thought to be compliant with a non-LMWH anticoagulant (or within the therapeutic range if receiving VKA therapy).
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
                  &nbsp;An increased dose of LMWH (one quarter to one third) is appropriate for patients with recurrent PE who have been receiving LMWH.
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  Patients with recurrent VTE
               </p>
               <p class="w-75">
                  <!-- col-md-9 -->
                  For patients who are no longer receiving anticoagulant therapy and experience a second unprovoked PE, guidelines recommend the following anticoagulant treatment durations:
                  <span class="reference"> 
                  <a href="#referencePop76" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[76]</a> 
                  <span class="citationText" aria-hidden="true">Konstantinides SV, Torbicki A, Agnelli G, et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Nov 14;35(43):3033-69.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://academic.oup.com/eurheartj/article/35/43/3033/503581
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/25173341?tool=bestpractice.com
                  </span>
                  </span>
                  <span class="reference"> 
                  <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                  <span class="citationText" aria-hidden="true">Kearon C, Akl EA, Ornelas J, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb;149(2):315-52.</span> 
                  <span class="citationFullTextUrl" aria-hidden="true">
                  https://journal.chestnet.org/article/S0012-3692(15)00335-9/fulltext
                  </span>
                  <span class="referenceUniqueId" aria-hidden="true">
                  http://www.ncbi.nlm.nih.gov/pubmed/26867832?tool=bestpractice.com
                  </span>
                  </span>
               </p>
               <ul class="w-75">
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        Low or moderate bleeding risk: extended anticoagulant therapy with periodic reassessment to review risk-benefit ratio
                     </p>
                  </li>
                  <li>
                     <p class="w-75">
                        <!-- col-md-9 -->
                        High bleeding risk: 3 months.
                     </p>
                  </li>
               </ul>
            </div>
         </div>
         <div class="card-block disclaimer">
            <p><span>Use of this content is subject to our <a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">disclaimer</a> </span></p>
         </div>
      </main>
      <script type="text/javascript" id="">(function(){var f=google_tag_manager["GTM-K3TZ3JV"].macro(4),b=google_tag_manager["GTM-K3TZ3JV"].macro(5),a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};f?"true"!=b&&("justLoggedIn"==b?a("loggedIn","true",2):a("loggedIn","justLoggedIn",2)):a("loggedIn","false",2)})();</script>
      <!-- set the messages country code variable from region to be used from i18 plugin. Setting here so it's available in all pages -->
      <script>
         /*<![CDATA[*/
         
         var messagesCountryCode = "en_GB";
         /*]]>*/
           
      </script>
      <aside id="panel-nhs" class="card-block">
         <div id="access" class="col-sm-6">
            <div class="row">
               <div class="col-md-6">
                  <p>Access provided by:</p>
               </div>
               <div class="col-md-6">
                  <img src="../images/bmj-logo.png" alt="BMJ Group (Online access from BMA House)">
               </div>
            </div>
         </div>
      </aside>
      <footer id="footer">
         <div class="container">
            <div class="row">
               <nav class="col-md-9" role="navigation">
                  <div class="row">
                     <dl class="col-md-4" role="menu">
                        <dt>Browse</dt>
                        <dd><a href="https://bestpractice.bmj.com/">Home</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/recent-updates">Recent updates</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/specialties">Specialties</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/calculators">Calculators</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/patient-leaflets">Patient leaflets</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/procedural-videos">Procedural videos</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/evidence">Evidence</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/drugs">Drugs</a></dd>
                     </dl>
                     <!-- logged-in individual or institutional user -->
                     <!-- unknown user -->
                     <!--institutional user not logged in-->
                     <dl class="col-md-4" role="menu">
                        <dt>Services</dt>
                        <dd><a href="https://bestpractice.bmj.com/login">Log in</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/registration">Create an account</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/" target="_blank">About us</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/app/" target="_blank">Mobile app</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></dd>
                        <dd>
                           <a href="https://myaccount.bmj.com/myaccount/registration.html?regService=bestpractice-email-alert&amp;fwdUrl=https://bestpractice.bmj.com">
                           Sign up for email alerts
                           </a>
                        </dd>
                     </dl>
                     <dl class="col-md-4" role="menu">
                        <dt>Legal</dt>
                        <dd><a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">Disclaimer</a></dd>
                        <dd><a href="https://www.bmj.com/company/legal-information/" target="_blank">Terms and conditions</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/" target="_blank">Privacy notice</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">Cookie policy</a></dd>
                     </dl>
                  </div>
                  <!-- row -->
               </nav>
               <div class="col-md-3">
                  <ul>
                     <li><a target="_blank" href="https://www.facebook.com/BMJBestPractice"><img alt="Facebook Logo" title="Facebook" src="../images/facebook-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://twitter.com/BMJBestPractice"><img alt="Twiter Logo" title="Twitter" src="../images/twitter-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.linkedin.com/showcase/15218227/"><img alt="LinkedIn Logo" title="LinkedIn" src="../images/linkedIn_logo_circle.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.youtube.com/channel/UCt72GZ0cPXpk4EzgFhdWYdQ"><img alt="Youtube Logo" title="YouTube" src="../images/youtube-64.png" width="60" height="60"></a></li>
                  </ul>
                  <p class="copyright mt-3"><small>© BMJ Publishing Group 2018</small></p>
                  <p class="issn"><small>ISSN 2515-9615</small></p>
               </div>
            </div>
            <!-- row -->  
         </div>
         <!-- container -->    
      </footer>
      <div class="container modal-registration-form" aria-hidden="true">
         <div id="feedbackContainer" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-header">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Help us improve <abbr>BMJ</abbr> Best Practice</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                        <div class="col-md-12">
                           <p>Please complete all fields.</p>
                        </div>
                     </div>
                  </div>
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <form id="feedbackForm" action="https://bestpractice.bmj.com/topics/en-gb/116/prevention#" novalidate="novalidate">
                              <div class="row">
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackName">Name</label> 
                                       <input id="feedbackName" class="form-control" name="feedbackName" type="text">
                                    </div>
                                 </div>
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackEmail">Email</label> 
                                       <input id="feedbackEmail" class="form-control" name="feedbackEmail" type="email" value="">
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <h2 id="feedbackPageTitle" class="h3">Page: Pulmonary embolism - Prevention | BMJ Best Practice</h2>
                                 </div>
                              </div>
                              <input id="feedbackPage" name="feedbackPage" type="hidden" value="Pulmonary embolism - Prevention | BMJ Best Practice">
                              <div class="row">
                                 <div class="col-md-4">
                                    <p>I have some feedback on:</p>
                                    <fieldset class="form-group" role="radiogroup">
                                       <legend>Feedback on: </legend>
                                       <label for="feedOn01"><input id="feedOn01" type="radio" name="feedbackOn" value="This page" checked="checked">&nbsp;This page</label>
                                       <label for="feedOn02"><input id="feedOn02" type="radio" name="feedbackOn" value="This website">&nbsp;The website in general</label>
                                       <label for="feedOn03"><input id="feedOn03" type="radio" name="feedbackOn" value="Something else">&nbsp;Something else</label>
                                    </fieldset>
                                 </div>
                                 <div class="col-md-8">
                                    <div class="form-group floating-label textarea">
                                       <label for="feedbackContent">I have some feedback on:</label>
                                       <textarea id="feedbackContent" name="feedbackContent"></textarea>
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <p>We will respond to all feedback.</p>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <button id="feedbackSubmit" type="submit" class="btn btn-secondary btn-lg">
                                    <span id="spinner2" class="progress-circular-inner progress-circular-left"></span>
                                    <span id="btnText2">Submit Feedback</span>
                                    </button>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-12">
                                    <p>For any urgent enquiries please contact our customer services team who are ready to help with any problems.</p>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-3">
                                    <p><b>Phone:</b> +44 (0) 207 111 1105</p>
                                 </div>
                                 <div class="col-md-3">
                                    <p><b>Email: </b> <a href="mailto:support@bmj.com">support@bmj.com</a></p>
                                 </div>
                              </div>
                           </form>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedbackSuccess" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackConfirmedLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Thank you</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                     </div>
                     <div class="row">
                        <div class="col-md-12">
                           <p>Your feedback has been submitted successfully.</p>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedBackBtn">
            <p role="button"><a href="https://bestpractice.bmj.com/topics/en-gb/116/prevention#"><span class="material-icons"></span>&nbsp;FEEDBACK</a></p>
         </div>
      </div>
      <script type="text/javascript" src="../js/common.js"></script>
      <script type="text/javascript" src="../js/main.js"></script>
      <script>
         // Code for the recently viewed topics suggestion, needs to be inlined to use the Java values
         /*<![CDATA[*/       
         function dedupe(array) {
           var seen = {};
           return array.filter(function(item) {
               return seen.hasOwnProperty(item.id) ? false : (seen[item.id] = true);
           });
         }
         function TopicViewed(id, title, lang) {
           this.id = id;
           this.title = title;
           this.lang = lang;
         }
         jQuery(document).ready(function() {
           var topicId = 116;
           var topicLang = "en-gb";
           var topicTitle = "Pulmonary embolism";
           if(topicId){
               
             var topicsViewed = [];
             if (localStorage.getItem("topicsViewed") !== null) {
               topicsViewed = JSON.parse(localStorage.topicsViewed);
             }
               
             topicsViewed.unshift(new TopicViewed(topicId, topicTitle, topicLang));// Add new topics at the beginning
             topicsViewed = dedupe(topicsViewed);// Remove duplicates
             if (topicsViewed.length > 15){// Drop if size is bigger than 15
               topicsViewed = topicsViewed.slice(0,14);  
             }
         
             localStorage.topicsViewed = JSON.stringify(topicsViewed);
           }
          });       
         /*]]>*/
      </script>
      <script type="text/javascript">
         _linkedin_data_partner_id = "103646";
      </script>
      <script type="text/javascript">
         (function()
         {var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);}
         )();
      </script>
      <script type="text/javascript" data-cfasync="false">
         (function(W,i,s,e,P,o,p){W['WisePopsObject']=P;W[P]=W[P]||function()
         { (W[P].q=W[P].q||[]).push(arguments)}
         ,W[P].l=1*new Date();o=i.createElement(s),
         p=i.getElementsByTagName(s)[0];o.async=1;o.src=e;p.parentNode.insertBefore(o,p)
         })(window,document,'script','//loader.wisepops.com/get-loader.js?v=1&site=qudyiEfMBd','wisepops');
         window.WisePopsLoaderCallback = function(wisepops) {
                         wisepops._storage.visits = wisepops._storage.visits.slice(0, 2);
                         wisepops._storage._saveVisits();
                       };
      </script>
      <noscript>
         <img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=103646&fmt=gif" />
      </noscript>
      <!--[if lte IE 7]><script>var isIE7OrOlder = true; </script><![endif]-->   
      <!--[if lte IE 9]><script type="text/javascript" src="/gzip_e7393341757851d76c3264b590cf5143/js/browserupdate.js" ></script>
      <![endif]-->
      <script src="../js/adsct" type="text/javascript"></script><script type="text/javascript" id="createCookie">(function(){var b="bestpractice.bmj.com\/topics\/en-gb\/116\/prevention",a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};a("RefTrack",b,2);a("RefTrackGroup","bestpractice.bmj.com",2)})();</script><script type="text/javascript" id="copyText">function getSelectionText(){var a="";window.getSelection?a=window.getSelection().toString():document.selection&&"Control"!=document.selection.type&&(a=document.selection.createRange().text);return a}document.addEventListener("copy",function(a){dataLayer.push({event:"textCopied",clipboardText:getSelectionText(),clipboardLength:getSelectionText().length})});</script>
      <script type="text/javascript" id="facebookPixel">!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version="2.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://connect.facebook.net/en_US/fbevents.js");fbq("init","414393182248444");fbq("track","PageView");</script>
      <noscript><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=414393182248444&amp;ev=PageView&amp;noscript=1"></noscript>
      <button id="scrollTop" class="material-scrolltop" type="button"><span class="material-icons"></span></button><script src="../js/saved_resource" type="text/javascript"></script>
   </body>
</html>